Insulet said its Board of Directors appointed Robbie Huffines as a Class II director on October 21, 2025, with the appointment effective October 31, 2025. He will stand for election by stockholders at the 2027 Annual Meeting of Stockholders.

1. 01

   Insulet said its Board of Directors appointed Robbie Huffines as a Class II director on October 21, 2025, with the appointment effective October 31, 2025. He will stand for election by stockholders at the 2027 Annual Meeting of Stockholders.

2. 02

   The company said Huffines was assigned to the Board's Audit Committee effective October 31, 2025 and joined as an independent director.

3. 03

   Insulet said Huffines served as Global Chair of Investment Banking at JP Morgan Chase & Co. from 2020 until his retirement in 2024, and began his career in 1992 in the mergers and acquisitions group focused on healthcare.

4. 04

   The company said there were no arrangements or understandings between Huffines and any other persons pursuant to which he was selected as a director, and there were no transactions involving him required to be disclosed under Item 404(a). As a non-employee director, he will receive cash and equity compensation pursuant to the Company's non-employee director compensation program.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.